What is the pathogenesis of Charcot Marie Tooth (CMT) disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathogenesis of Charcot-Marie-Tooth Disease

CMT disease results from genetic mutations affecting peripheral nerve structure and function, leading to either myelin sheath abnormalities (demyelinating forms) or direct axonal damage (axonal forms), with the ultimate common pathway being length-dependent axonal degeneration that produces the characteristic distal phenotype. 1

Genetic Mechanisms

The pathogenesis begins at the molecular level with mutations in over 40 different genes, each affecting distinct cellular functions in peripheral nerves 2, 3:

  • CMT1A (demyelinating form) - The most common subtype (70% of CMT1 cases) results from duplication of the PMP22 gene on chromosome 17p12, causing abnormal myelin formation and maintenance 4, 5

  • CMT2 (axonal form) - Most frequently caused by MFN2 mutations (33% of CMT2 cases), which disrupt mitochondrial fusion and axonal transport mechanisms 4, 5

  • CMTX (X-linked form) - Results from Cx32(GJB1) mutations affecting gap junction proteins, accounting for 12% of all CMT cases and producing either demyelinating or axonal patterns 4, 5

Cellular Pathophysiology

The disease mechanisms vary by genetic subtype but converge on common pathways 1:

  • Demyelinating forms (CMT1) - Mutations in myelin-related genes (PMP22, MPZ, EGR2) cause abnormal myelin development or degeneration, resulting in uniformly slowed nerve conduction velocities 4, 1

  • Axonal forms (CMT2) - Mutations affect axonal transport, mitochondrial function, or cytoskeletal proteins, leading to primary axonal degeneration with relatively preserved myelin 4, 1

  • Length-dependent degeneration - Regardless of the primary defect (myelin or axon), the final common pathway involves length-dependent axonal degeneration, explaining why the longest nerves (to distal limbs) are affected first and most severely 1

Progressive Nerve Dysfunction

The pathogenic process unfolds progressively 6, 2:

  • Mutations cause either abnormal development or degeneration of peripheral nerves starting in infancy in most cases 6, 3

  • The distal-to-proximal gradient of nerve dysfunction produces the characteristic "stork leg" appearance from peroneal muscle atrophy 5

  • Secondary skeletal deformities (pes cavovarus) develop from chronic muscle imbalance 5, 6

Pathophysiological Heterogeneity

Important nuances exist across subtypes 1, 7:

  • CMTX shows asymmetric and nonhomogeneous conduction slowing, unlike the uniform slowing in CMT1A, sometimes mimicking acquired inflammatory neuropathies 1, 7

  • Some genes produce variable phenotypes - different mutations in the same gene can cause either demyelinating or axonal forms 1

  • Recessive forms (CMT4) typically have earlier onset and more severe progression than dominant types 1

  • Some CMT1 cases (especially CMT1B and CMT2A) show inflammatory macrophage infiltration, suggesting secondary inflammatory mechanisms that may respond to immunomodulation 7

Clinical-Pathological Correlation

The pathogenesis directly explains clinical manifestations 5, 6:

  • Progressive distal muscle weakness and atrophy result from length-dependent axonal loss 5, 1

  • Sensory deficits in "glove and stocking" distribution reflect the same length-dependent process 5

  • Areflexia develops from sensory nerve involvement affecting reflex arcs 1

  • Foot deformities arise from chronic imbalance between intrinsic and extrinsic foot muscles 5, 6

References

Research

The various Charcot-Marie-Tooth diseases.

Current opinion in neurology, 2013

Research

Diagnosis of Charcot-Marie-Tooth disease.

Journal of biomedicine & biotechnology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Charcot-Marie-Tooth Disease Clinical Features and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Charcot-Marie-tooth disease.

Foot & ankle specialist, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.